SAR
Fiscal year ends February Quarters are offset from the calendar — Q1 is Mar–May

Saratoga Investment Corp is a specialty finance company and externally managed closed-end management investment company that provides customized financing solutions to U.S. middle-market businesses. The company primarily invests in senior and unitranche leveraged loans, mezzanine debt, and equity issued by private U.S. companies, focusing on change of ownership transactions, strategic acquisitions, recapitalizations, and growth initiatives. Its investment activities are externally managed by Saratoga Investment Advisors, LLC, which is affiliated with Saratoga Partners, a middle-market private equity investment firm. The portfolio includes first lien term loans, second lien term loans, unsecured loans, structured finance securities, and equity interests. Saratoga Investment Corp also maintains wholly owned subsidiaries, Saratoga Investment Corp. SBIC II LP and Saratoga Investment Corp. SBIC III LP, which operate as small business investment companies licensed by the Small Business Administration. The company serves business owners, management teams, founders, private equity firms, and intermediaries seeking flexible capital structures for complex growth needs.

Summarised from the company's own disclosures, fiscal year ended May 2026

Industry Asset Management Homepage saratogapartners.com
Sector Financial Services IR page ir.saratogainvestmentcorp.com
Tags
business development company, middle-market lending, leveraged loans, mezzanine debt, private credit, structured finance, small business investment company, direct lending, equity investments, special situations, Saratoga Investment Advisors LLC, Saratoga Partners, Saratoga Investment Corp. SBIC II LP, Saratoga Investment Corp. SBIC III LP, Saratoga Investment Corp. CLO 2013-1 Ltd., Saratoga Senior Loan Fund I JV LLC
Press page —

Metrics

Valuation  
Market cap $ 236.033M
Market cap (USD) $ 236.033M
P/E -54.93
PEG —
P/BV 0.67
P/S 4.73
Discount/premium to NAV -5.5%
P/OCF -1.53
P/FCF -2.68
Dividend yield 0.61%
Turnover / mcap —
Returns  
ROE 9.3%
ROI 3.2%
ROIC 3.2%
Profit margin 73.3%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y No
Revenue up 5y —
Earnings growth 3y (net profit CAGR) 14.0%
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock No
Diluting (TTM) No
Debt/Equity 255.9%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 13
Quality score 17.6%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008
Revenue 49.918M 42.104M 20.365M 36.353M 57.582M 47.708M 36.845M 33.157M 30.051M 27.375M 0 17.007M 13.512M 14.173M 15.617M — —
Net profit 36.604M 28.086M 8.934M 24.676M 45.735M 18.509M 14.203M 11.387M 11.646M 11.007M — 14.602M 13.275M 16.958M -10.463M — —
Free cash flow -88.03M 197.539M -157.207M -130.374M -203.134M — — — — — — — — — — — —

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008
Share price 23.07 23.92 25.86 25.49 — 22 21.65 20.6 14.53 15.4 — 14.1 14.1 19.22 — — —
Price performance 12m -0.04 -0.08 0.01 -0.13 — -0.02 — 0.42 -0.06 -0.02 — 0 -0.27 — — — —

Filed figures

Figure Feb 2017 Feb 2018 Feb 2019 Feb 2020 Feb 2021 Feb 2022 Feb 2023 Feb 2024 Feb 2025 Feb 2026
Balance sheet detail
Borrowings, non-current (USD) — — — — — — — 820,375 — —
Cash and deposits (USD) — — — 39.5M 29.9M 47.3M 65.7M 8.69M 148M 1.68M
Net debt (borrowings + leases - cash) (USD) — — — — — — — -7.87M — —
Cash flow detail
Operating cash flow (USD) 6.74M -30.8M -40M — -62.3M -203M -130M -157M 198M -88M
Change in receivables (cash effect) (USD) 1,090 — — — — — — — — —
Change in payables (cash effect) (USD) -99,719 215,458 691,131 — 37,109 -951,208 665,285 -126,801 338,793 95,580
Dividends paid (cash effect) (USD) 6.79M 9.01M 12M — -11.3M -18.2M -22.7M -32.1M -40.7M -52.4M
Share buybacks (cash effect) (USD) 3.33M 0.00 0.00 — — — -10.8M -2.16M — -54,314
Interest paid (cash effect) (USD) -7.64M -9.71M -11.7M — -11.8M -17.6M -28.9M -44.1M -46.7M -44.5M
Income taxes paid (cash effect) (USD) -144,247 -208,164 -66,295 — -4.14M -1.36M -2.77M -748,721 -791,645 -2.23M
Operating cash flow before change in receivables (USD) 6.74M — — — — — — — — —
Reported May 16, 2017 May 14, 2018 May 14, 2019 May 2, 2023 May 2, 2023 May 2, 2023 May 7, 2025 May 7, 2025 May 7, 2025 May 5, 2026

Operating KPIs — quarters

KPI Nov 24 Feb 25 May 25 Aug 25 Nov 25 Feb 26 May 26 Aug 26
Assets under management (USD) 960M 978M 968M 995M 1.02B 1.11B 1.13B 1.15B
↳ YoY growth -14.1% +5.8% +13.4% +16.3% +15.6%
Reported Jan 7, 2026 May 5, 2026 Jul 7, 2026 Jan 7, 2026 Jan 7, 2026 May 5, 2026 Jul 7, 2026 Oct 6, 2026

Operating KPIs — years

KPI Feb 2024 Feb 2025 Feb 2026
Assets under management (USD) 1.14B 978M 1.11B
↳ YoY growth -14.1% +13.4%
Reported May 5, 2026 May 5, 2026 May 5, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

On October 8, 2026, Saratoga Investment Corp. (the “Company”) and its wholly owned financing subsidiary, Saratoga Investment Funding II LLC (“SIF II” or the “Borrower”), entered into the First Amendment to the Credit and Security Agreement (the “Amendment” and as amended by the Amendment, the “Credit Agreement”), by and among SIF II, as borrower, the Company, as collateral manager and as equityholder, the lenders parties thereto, Valley National Bank, as administrative agent, and U.S. Bank Trust Company, National Association, as collateral agent, and collateral administrator (the “Valley Credit Facility”).

<< Back

Oct 6, 2026

Saratoga Investment Corp. Announces Fiscal Second Quarter 2027 Financial Results

Reports Quarterly Asset Growth of 2.1% and Net Originations of $37.1 Million, Including Two New Portfolio Companies

Non-Accruals Remain Low at 0.0% of Fair Value and 1.3% of Cost

Repurchase of 444,124 Shares, Contributing $0.09 Per Share of NAV Accretion

NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Saratoga Investment Corp. (NYSE: SAR) (“Saratoga Investment” or “the Company”), a business development company (“BDC”), today announced financial results for its fiscal second quarter 2027 ended August 31, 2026.

Summary Financial Information The Company’s summarized financial information is as follows:

| | For the three months ended and as of |

| ($ in thousands, except per share) | August 31, 2026 | May 31, 2026 | August 31, 2025 |

| Assets Under Management (AUM) | 1,150,190 | 1,126,334 | 995,295 |

| Net Asset Value (NAV) | 352,577 | 378,455 | 410,500 |

| NAV per share | 22.15 | 23.23 | 25.61 |

| Total Investment Income | 31,169 | 30,777 | 30,626 |

| Net Investment Income (NII) per share | 0.45 | 0.47 | 0.58 |

| Adjusted NII per share | 0.46 | 0.47 | 0.58 |

| Earnings per share | (0.41) | (0.42) | 0.84 |

| Dividends per share (record date) | 0.75 | 0.75 | 0.75 |

| Return on Equity – last twelve months | (1.1%) | 4.0% | 9.1% |

| – annualized quarter | (7.3%) | (7.1%) | 13.8% |

| Originations | 76,113 | 79,151 | 52,222 |

| Repayments | 39,048 | 48,415 | 29,824 |

Positive highlights during and subsequent to the quarter include:

  • High-quality AUM growth of 2.1% sequentially, including two new non-software portfolio companies,

  • Issuance of an $85.0 million SAX baby bond, which subsequent to quarter-end increased to $120.8 million through exercise of the green shoe and reopening of the issuance. This issuance allowed for refinancing of the $105.5 million SAT baby bond, reducing refinancing risk for next year. Opportunistically issued prior to Labor Day and subsequent increases in interest rates and competitive offerings,

  • Repurchases of 444,124 shares at a discount to NAV resulting in a $0.09 per share NAV per share accretion,

  • Took advantage of robust refinancing environment to reset CLO1 at $350 million at lower rates, three-year reinvestment period, future BDC management fees and significantly improved interest income,

  • Significant Zollege investment appreciation, and

  • Both Pepper Palace and the CLO F-Note have been sold post quarter-end, thereby eliminating all remaining non-accrual investments, and recently our Exigo red investment was also fully exited at $8.0 million, resulting in a -6.1% IRR over the life of the investment.

Headwinds during the quarter:

  • Balance sheet refinancing resulting in additional interest expense from higher cost debt while spreads on assets not yet widening, although recent base rate increases will benefit interest income,

  • NAV per share decline includes $0.82 per share specifically related to company performance in three distinct credits, and $0.30 per share related to dividend distributions exceeding net investment income, offset by $0.09 per share appreciation from share repurchases, and

  • $13.3 million of $25.9 million NAV decline from accretive share repurchases (32%) and excess dividend distribution (19%) of previously undistributed earnings, which reduces the Company spillover obligation.

Christian L. Oberbeck, Chairman and Chief Executive Officer of Saratoga Investment, commented, “Our second-quarter results demonstrate the resilience of our platform despite the continued pressure affecting private credit markets. We grew assets under management by 2.1% to $1.150 billion, generating $37.1 million of net originations, while adjusted NII remained relatively stable at $0.46 per share including the cost of our recently refinanced capital structure. Although company-specific valuation adjustments, most previously highlighted in Q1, reduced NAV during the quarter, our core BDC portfolio ended the period only 1.6% below cost, and non-accrual investments represented 0.0% of total portfolio fair value and 1.3% of cost, with both the F-Note and Pepper Palace being sold after quarter-end. We believe these results reflect the underlying quality of the overall portfolio and our ability to continue deploying capital selectively in a volatile market.”

“Continuing our track record of strong dividend distributions, we recently announced a base monthly dividend of $0.25 per share, or $0.75 per share in aggregate for the third quarter of fiscal 2027. Our annualized third quarter dividend of $0.75 per share represents an 18.1% yield based on the stock price of $16.61 as of October 5, 2026, offering strong current income. Originations and AUM growth during the quarter contributed to adjusted NII of $0.46 per share, compared to $0.47 per share last quarter. The modest sequential decline reflected higher interest income from portfolio growth, including new originations and BB and BBB CLO debt investments, offset by the full-period impact of our recent refinancing activity.”

“Investment activity remained healthy during the quarter, supported by the continued expansion of our business development capabilities and sponsor relationships. Market dynamics continued to be very competitive. Despite this, we originated $76.1 million of investments, including investments in two new portfolio companies and nine follow-on investments, compared with $39.0 million of repayments, resulting in $37.1 million of net originations. Approximately $9.2 million of the quarter’s originations consisted of BB and BBB CLO debt investments. While competition remains significant and sentiment across private credit continues to be cautious, we remain highly selective and disciplined in evaluating opportunities given the uncertain operating environment. Our strong reputation, differentiated market positioning, and the ongoing development of sponsor relationships continue to create attractive investment opportunities from high-quality sponsors. We remain prudent and discerning in our underwriting approach, particularly in light of the current volatile and uncertain environment.”

“Saratoga’s overall performance is reflected in our key performance indicators this past quarter and year, including: (i) an increase in AUM of $23.9 million, or 2.1%, to $1.150 billion from the previous quarter, and $154.9 million, or 15.6%, from the previous year, (ii) NAV decrease of $25.9 million, or 6.8%, to $352.6 million from the previous quarter, with 49% of the decline due to portfolio adjustments and 51% due to excess dividend distributions and share repurchases, (iii) LTM ROE of (1.1)% as compared to the industry average of 2.2%, (iv) adjusted NII of $0.46 versus $0.47 per share last quarter, (v) EPS of $(0.41) per share versus $(0.42) in the previous quarter, and (vi) total dividends of $0.75 per share, unchanged from last quarter and last year.”

“NAV per share is down by 4.6% from $23.23 per share last quarter to $22.15 per share in Q2. Of the $1.08 per share reduction this quarter, $0.90 per share was attributable to unrealized depreciation on investments discussed below, and $0.30 per share distribution of dividends in excess of earnings, partially offset by $0.09 per share of accretion from net share repurchases.”

“Our total $1.150 billion portfolio was marked down $14.4 million during the quarter from realized gains and unrealized depreciation. The non-CLO portfolio had $15.4 million of net depreciation, driven primarily by $13.1 million of markdowns in Madison Logic, Exigo and Chronus, reflecting company performance adjustments, and the sales of Gen4 and Modis that resulted in a $1.5 million reversal of previously recognized unrealized appreciation, while other marks reflected a combination of lower equity market multiples and changes in market spreads. These declines were partially offset by $4.5 million of unrealized appreciation in Zollege. The CLO1’s F Note remained at zero fair value, the JV was written down $1.1 million, representing primarily the effect of $0.8 million of dividend income that reduced fair value, and the BB and BBB portfolio was relatively flat. We also recognized $2.1 million of realized gains, primarily from the Gen4 and Modis Dental equity conversions as part of a merger transaction. At quarter-end, our core BDC portfolio was 1.6% below cost and the total portfolio was 4.9% below cost.”

“During the quarter, our core non-CLO net interest margin increased by $0.2 million to $13.6 million. The average core assets increase of 1.2% and 5 basis points increase in the average SOFR rate used in the portfolio, was offset by (i) spreads on originations this quarter being 220 basis points lower than the repayments they replaced, and (ii) increased interest expense due to changes in our capital structure. Shares issued under the DRIP were fully offset by share repurchases, resulting in no net dilution.”

“Our quarter-end cash position increased from $60.8 million last quarter to $95.9 million, and used subsequent to quarter-end to redeem the $105.5 million SAT baby bond that was called.”

“Our overall credit quality remained solid this quarter, with 96.0% of credits rated in our highest internal category, a result we are proud of given the current headwinds in the industry, as further seen in this quarter’s markdowns. Pepper Palace and our CLO’s F Note remained on non-accrual and at zero fair value, together representing 0.0% of portfolio fair value and 1.3% of portfolio cost. With 81.5% of our investments at quarter-end in first lien debt, generally supported by strong enterprise values and resilient balance sheets in industries that have historically performed well in stressed situations, we believe our portfolio composition and leverage profile are well structured to handle a wide range of economic conditions and uncertainty.”

Mr. Oberbeck concluded, “As we reach the halfway point of fiscal year 2027, the operating environment remains uneven as geopolitical uncertainty, persistent inflation, interest-rate volatility and concerns regarding AI-related disruption within the software sector continue to affect borrowers and valuations. These conditions have contributed to higher default activity, declining NAVs across the industry and dividend reductions by several BDCs. At Saratoga, however, the NAV decline this quarter was concentrated in a limited number of company-specific situations and does not appear to reflect broad-based deterioration across the portfolio. At the same time, strong BDC debt issuance, firmer values for higher-quality loans and improving M&A activity point to a market that appears to be stabilizing and increasingly differentiating among managers. We remain confident that our disciplined, senior secured, first-lien focused underwriting and well-structured balance sheet position Saratoga to navigate this environment and continue delivering durable, risk-adjusted returns to our shareholders over the long term.”

Discussion of Financial Results for the Quarter ended August 31, 2026:

  • AUMat fair value as of August 31, 2026 was $1.150 billion, an increase of 2.1% from $1.126 billion as of last quarter, and an increase of 15.6% from $995.3 million as of August 31, 2025.

  • Total investment income for the three months ended August 31, 2026, was $31.2 million, an increase of $0.6 million, or 2.0%, from $30.6 million for the quarter ended August 31, 2025, and an increase of $0.4 million, or 1.3%, as compared to $30.8 million for the quarter ended May 31, 2026. This quarter’s investment income increase, as compared to prior quarters, was primarily due to the full-quarter impact of Q1 originations and the partial-quarter impact of Q2 originations more than offsetting repayments. Investment income reflects a weighted average interest rate on the core BDC portfolio of 10.6%, up from 10.5% as of May 31, 2026 and down from 11.3% as of August 31, 2025, and starting to reflect recent SOFR base rate increases.

  • Total expenses for the quarter ended August 31, 2026, excluding interest and debt financing expenses, base management fees and incentive fees, and income and excise taxes, were $2.9 million, an increase of $0.4 million compared to $2.5 million for the quarter ended August 31, 2025, and an increase of $0.2 million as compared to $2.7 million for the quarter ended May 31, 2026. This represented 0.9% of average total assets on an annualized basis, unchanged from 0.9% last quarter and up from 0.8% last year.

  • Adjusted NII for the quarter ended August 31, 2026, was $7.4 million, or $0.46 per share, compared with $9.1 million, or $0.58 per share, for the quarter ended August 31, 2025 and $7.6 million, or $0.47 per share, for the quarter ended May 31, 2026. The modest sequential decline primarily reflected the impact of the recent changes to the capital structure increasing interest expense, as well as (i) slight decreases in other income from lower structuring, advisory and prepayment fees, and (ii) higher base management fees from higher AUM.

  • NII Yield as a percentage of average net asset value for the quarter ended August 31, 2026, was 8.0%. Adjusted NII Yield was 8.1%, as compared to adjusted NII Yield of 9.0% last year, and 7.8% last quarter.

  • NAVwas $352.6 million as of August 31, 2026, a decrease of $57.9 million from $410.5 million as of August 31, 2025, and a decrease of $25.9 million from $378.5 million as of May 31, 2026.

  • NAV per share was $22.15 as of August 31, 2026, compared to $23.23 as of May 31, 2026, and $25.61 as of August 31, 2025.

  • Return on equity (“ROE”) for the last twelve months ended August 31, 2026, was (1.1%), compared with 9.1% for the comparable period last year, and 4.0% for the twelve months ended May 31, 2026. ROE on an annualized basis for the quarter ended August 31, 2026 was (7.3)%.

  • Repurchased 444,124 shares of common stock under our Share Repurchase Plan at an average price of $18.91 per share for approximately $8.4 million during the quarter. The shares were repurchased below NAV, generating approximately $0.11 per share of NAV accretion and fully offsetting shares issued under the Company’s dividend reinvestment plan.

  • The weighted average common shares outstanding for the quarter ended August 31, 2026 was 16.2 million, down from 16.3 million shares last quarter and increasing from 15.8 million for the quarter ended August 31, 2025.

Portfolio and Investment Activity for the Quarter Ended August 31, 2026

  • Fair value of Saratoga Investment’s portfolio was $1.150 billion, excluding $95.9 million in cash and cash equivalents, principally invested in 50 portfolio companies, one collateralized loan obligation fund (the “CLO”), one joint venture fund (the “JV”), and 32 distinct BB and BBB CLO debt investments.

  • Cost of investmentsmade during the quarter ended August 31, 2026 were $76.1 million, including two investments in new portfolio companies and nine follow-on investments. Cost of investments made during the six months ended August 31, 2026 were $155.3 million.

  • Principal repaymentsduring the quarter ended August 31, 2026, were $39.0 million, including two full debt repayments and equity realizations, four partial repayments, plus amortization. Principal repayments for the six months ended August 31, 2026 were $87.5 million.

  • For the quarter ended August 31, 2026, the fair value of the portfolio decreased by $14.4 million of net realized gains and unrealized depreciation, consisting primarily of (i) $15.4 million of net depreciation in the non-CLO core portfolio, (ii) a $1.1 million write down in the JV, and (iii) $2.1 million of net realized gains, primarily from the Gen4 and Modis Dental equity conversions.

  • The $15.4 million of net depreciation in the non-CLO core portfolio consisted primarily of three components:

  • Madison Logic, Exigo and Chronus continued to decline and represented $13.1 million of the quarter’s write-downs;

  • The equity conversions of Gen4 and Modis resulted in a $1.5 million reversal of previously recognized unrealized appreciation; and

  • The remaining portfolio marks reflected numerous lower equity market multiples in certain equity positions and the impact of changes in market spreads across the portfolio, offset by $4.5 million of unrealized appreciation in Zollege.

  • Since taking over management of the BDC in 2010, the Company has generated $1.41 billion of repayments and sales of investments originated by Saratoga Investment, generating a gross unlevered IRR of 14.9%. Total investments originated by Saratoga are $2.66 billion in 134 portfolio companies.

  • The overall portfolio composition consisted of 81.5% of first lien term loans, 3.9% of second lien term loans, 1.4% of unsecured loans, 6.1% of structured finance securities, and 7.1% of common equity.

  • The weighted average current yield on Saratoga Investment’s portfolio based on current fair values was 9.9%, which was comprised of a weighted average current yield of 10.5% on first lien term loans, 12.0% on second lien term loans, 11.4% on unsecured loans, 10.9% on structured finance securities and 0.0% on equity interests.

  • On September 17, 2026, the Company completed the sixth refinancing of the Saratoga CLO. This refinancing, among other things, extended the Saratoga CLO reinvestment period to October 2029, extended its legal maturity to October 2037, and established a non-call period ending in April 2028. This new Saratoga CLO will have approximately $350 million in assets. As part of this refinancing, we invested an additional $16.2 million in newly issued subordinated notes of the Saratoga CLO and purchased $2.6 million in aggregate principal amount of its Class E-2-R5 notes tranche at par.

Liquidity and Capital Resources

Outstanding Borrowings:

  • On August 26, 2026, we issued $85.0 million in aggregate principal amount of 8.00% fixed-rate notes due 2031 (the “8.00% 2031 Notes”) for net proceeds of approximately $82.3 million. Estimated offering costs incurred were approximately $0.3 million. Interest on the 8.00% 2031 Notes is paid quarterly on February 28, May 31, August 31 and November 30 of each year, with the first payment to be made on November 30, 2026. The Notes will mature on August 31, 2031. The 8.00% 2031 Notes may be redeemed in whole or in part at any time or from time to time at the Company’s option on or after August 26, 2028. The Company has granted the underwriters an option to purchase up to an additional $12.75 million in aggregate principal amount of Notes, and on September 2, 2026, the underwriters fully exercised their option for net proceeds to the Company of $12.4 million after deducting underwriting commissions of approximately $0.4 million. In addition, on September 24, 2026, the Company issued an additional $23.1 million in aggregate principal amount of its 8.00% Notes due 2031, including $3.0 million pursuant to the underwriters’ exercise in full of their over-allotment option. Net proceeds to the Company were $22.5 million, based on the public offering price of 99.6% of the aggregate principal amount, after deducting underwriting commissions of approximately $0.5 million and estimated offering expenses of $0.2 million. The Notes are listed on the NYSE under the trading symbol “SAX”. The Company has received an investment grade private rating of “BBB” from Egan-Jones Ratings Company, an independent, unaffiliated rating agency.

  • As of August 31, 2026 Saratoga Investment had $902.4 million of borrowings outstanding, including $32.5 million under its $85.0 million senior secured revolving Valley Credit Facility and $37.5 million under its $75.0 million senior secured revolving Live Oak Credit Facility.

  • In addition, Saratoga Investment had $84.0 million of SBA debentures in its SBIC II license outstanding, $129.0 million of SBA debentures in its SBIC III license outstanding, $454.4 million of listed baby bonds issued, $75.0 million of unsecured unlisted institutional bond issuances, four unlisted private issuances of $90.0 million in total, and an aggregate of $95.9 million in cash and cash equivalents.

  • On September 18, 2026, the Company redeemed, in full, $105.5 million aggregate principal amount of the issued and outstanding 6.00% 2027 Notes. The 6.00% 2027 Notes were redeemed at 100% of their principal amount, plus the accrued and unpaid interest thereon, through, but excluding, the date of redemption.

Undrawn Borrowing Capacity:

  • With $90.0 million available under the two credit facilities and $95.9 million of cash and cash equivalents as of August 31, 2026, Saratoga Investment has a total of $185.9 million of undrawn credit facility borrowing capacity and cash and cash equivalents available, however this cash and the additional bond proceeds raised on September 2, 2026 is to be used for the repayment of the 6.00% 2027 Notes. The available credit facility can be used for new investments or to support existing portfolio companies in the BDC and the SBIC.

  • In addition, Saratoga Investment has $46.0 million in undrawn SBA debentures available from its existing SBIC III license. And in May 2026, legislation amending the Small Business Investment Act of 1958 increased the individual SBIC leverage limit from $175.0 million to $250.0 million, and the maximum leverage available for two or more SBICs under common control from $350.0 million to $475.0 million, in each case subject to SBA approvals. On September 4, 2026, the Company received notification from the SBA that SBIC III’s individual leverage limit was increased to $250.0 million, providing an additional $75.0 million of long-term capital in the form of SBA-guaranteed debentures.

  • Availability under the Valley National Bank and Live Oak credit facilities can change depending on portfolio company performance and valuation. In addition, certain follow-on investments in SBIC II and the BDC will not qualify for SBIC III funding.

  • Total Saratoga Investment undrawn borrowing capacity is therefore $136.0 million as of August 31, 2026.

  • As of August 31, 2026, Saratoga Investment had $120.0 million of committed undrawn lending commitments and $61.1 million of discretionary funding commitments.

Additionally:

  • Saratoga Investment has an active equity distribution agreement with Ladenburg Thalmann & Co. Inc., Raymond James and Associates, Inc, Lucid Capital Markets, LLC and Compass Point Research and Trading, LLC, through which the Company may offer for sale, from time to time, up to $300.0 million of common stock through an ATM offering.

  • As of August 31, 2026, Saratoga Investment has sold 8,591,915 shares for gross proceeds of $227.2 million at an average price of $26.42 for aggregate net proceeds of $225.4 million (net of transaction costs).

  • During the three and six months ended August 31, 2026, Saratoga Investment did not sell any shares through its ATM Program.

Dividend

On September 9, 2026, Saratoga Investment announced that its Board of Directors declared a base quarterly dividend of $0.75 per share in aggregate for the third quarter of fiscal 2027, declaring the following three monthly $0.25 per share dividends:

| Month | | Amount Per Share | | Record Date | | Payment Date |

| September 2026 | | $0.25 | | October 6, 2026 | | October 22, 2026 |

| October 2026 | | $0.25 | | November 5, 2026 | | November 24, 2026 |

| November 2026 | | $0.25 | | December 3, 2026 | | December 22, 2026 |

Shareholders have the option to receive payment of dividends in cash or receive shares of common stock, pursuant to the Company’s DRIP. Shares issued under the Company’s DRIP are issued at a 5% discount to the average market price per share at the close of trading on the ten trading days immediately preceding (and including) the payment date.

The following table highlights Saratoga Investment’s monthly dividend distribution for fiscal 2027 and annual distribution over the past five years:

| Period (Fiscal Year ends Feb) | Base Dividend Per Share | Special Dividend Per Share | Total Dividend Per Share |

| Fiscal Q3 2027 (November 2026) | $0.25 | - | $0.25 |

| Fiscal Q3 2027 (October 2026) | $0.25 | - | $0.25 |

| Fiscal Q3 2027 (September 2026) | $0.25 | - | $0.25 |

| Fiscal Q2 2027 (August 2026) | $0.25 | - | $0.25 |

| Fiscal Q2 2027 (July 2026) | $0.25 | - | $0.25 |

| Fiscal Q2 2027 (June 2026) | $0.25 | - | $0.25 |

| Fiscal Q1 2027 (May 2026) | $0.25 | - | $0.25 |

| Fiscal Q1 2027 (April 2026) | $0.25 | - | $0.25 |

| Fiscal Q1 2027 (March 2026) | $0.25 | - | $0.25 |

| Total Declared in Fiscal 2027 YTD | **$**2.25 | - | $2.25 |

| Full Year Fiscal 2026 | **$**3.00 | **$**0.25 | $3.25 |

| Full Year Fiscal 2025 | **$**2.96 | **$**0.35 | $3.31 |

| Full Year Fiscal 2024 | **$**2.86 | - | $2.86 |

| Full Year Fiscal 2023 | **$**2.44 | - | $2.44 |

Share Repurchase Plan

As of August 31, 2026, the Company purchased 1,481,822 shares of common stock, at the average price of $21.11 for approximately $31.3 million pursuant to the Share Repurchase Plan. During the three and six months ended August 31, 2026, the Company purchased 444,124 shares of common stock, at an average price of $18.91 for approximately $8.4 million pursuant to the Share Repurchase Plan.

Previously, in fiscal year 2015, the Company announced the approval of an open market share repurchase plan (the “Share Repurchase Plan”) that allows it to repurchase up to 200,000 shares of its common stock at prices below its NAV as reported in its then most recently published financial statements. Since then, the Share Repurchase Plan has been extended annually, and the Company has periodically increased the amount of shares of common stock that may be purchased under the Share Repurchase Plan, most recently to 2.7 million shares of common stock. On January 6, 2026, its Board of Directors extended the Share Repurchase Plan for another year to January 15, 2027.

Fiscal Second Quarter 2027 Conference Call/Webcast Information

| When: | Wednesday, October 7, 2026 |

| | 10:00 a.m. Eastern Time (ET) |

| | |

| How: | Webcast: Interested parties may access a live webcast of the call and find the Q2 2027 presentation by going to the “Events & Presentations” section of Saratoga Investment Corp.’s investor relations website, Saratoga events and presentations. A replay of the webcast will also be available for a limited time at Saratoga events and presentations. |

| | |

| Call: | To access the call by phone, please go to the Registration Link, and you will be provided with dial-in details. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. |

About Saratoga Investment Corp.

Saratoga Investment is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses. The Company invests primarily in senior and unitranche leveraged loans and mezzanine debt, and, to a lesser extent, equity to provide financing for change of ownership transactions, strategic acquisitions, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors. Saratoga Investment’s objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from its debt and equity investments. Saratoga Investment has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended, and is externally managed by Saratoga Investment Advisors, LLC, an SEC-registered investment advisor focusing on credit-driven strategies. Saratoga Investment Corp. owns two active SBIC-licensed subsidiaries, having surrendered its first license after repaying all debentures for that fund following the end of its investment period and subsequent wind-down. Furthermore, it manages a $350 million collateralized loan obligation (“CLO”) fund that has recently repriced and reset its reinvestment period and co-manages a joint venture (“JV”) fund that owns a $400 million collateralized loan obligation (“JV CLO”) fund. It also owns 50% of the Class E2R5 notes and 100% of the subordinated notes of the CLO, 87.5% of both the unsecured loans and membership interests of the JV and 87.5% of the Class E-R notes of the JV CLO. The Company’s diverse funding sources, combined with a permanent capital base, enable Saratoga Investment to provide a broad range of financing solutions.

Forward Looking Statements

This press release contains historical information and forward-looking statements with respect to the business and investments of the Company, including, but not limited to, the statements about future events or our future performance or financial condition. Forward-looking statements can be identified by the use of forward looking words such as “outlook,” “believes,” “expects,” “potential,” “continues,” “may,” “will,” “should,” “seeks,” “approximately,” “predicts,” “intends,” “plans,” “estimates,” “anticipates” or negative versions of those words, other comparable words or other statements that do not relate to historical or factual matters. The forward-looking statements are based on our beliefs, assumptions and expectations of our future performance, taking into account all information currently available to us. These statements are not guarantees of future performance, condition or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including, but not limited to: changes in the markets in which we invest; changes in the financial, capital, and lending markets; an economic downturn or a recession and its impact on the ability of our portfolio companies to operate and the investment opportunities available to us; the impact of interest rate volatility on our business and our portfolio companies; the uncertainty associated with the imposition of tariffs and trade barriers and changes in trade policy and its impact on our portfolio companies and the global economy; the impact of supply chain constraints and labor shortages on our portfolio companies; and the elevated levels of inflation and its impact on our portfolio companies and the industries in which we invest, as well as those described from time to time in our filings with the Securities and Exchange Commission.

Any forward-looking statement speaks only as of the date on which it is made. The Company undertakes no duty to update any forward-looking statements made herein or on the webcast/conference call, whether as a result of new information, future developments or otherwise, except as required by law. Readers should not place undue reliance on any forward-looking statements and are encouraged to review the Company’s Annual Report on Form 10-K for the fiscal year ended February 28, 2026 and subsequent filings, including the “Risk Factors” sections therein, with the Securities and Exchange Commission for a more complete discussion of the risks and other factors that could affect any forward-looking statements.

On September 23, 2026, Saratoga Investment Corp. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) by and among the Company and Saratoga Investment Advisors, LLC, on the one hand, and Lucid Capital Markets, LLC, as representative of the several underwriters named in Schedule I thereto (the “Underwriters”), on the other hand, in connection with the issuance and sale of an additional $23,092,350 in aggregate principal amount (inclusive of the Underwriters’ exercise of their overallotment option) of the Company’s 8.00% Notes due 2031 (NYSE: SAX) (the “New Notes” and the issuance and sale of the New Notes, the “Offering”).

The Underwriting Agreement includes customary representations, warranties, and covenants by the Company. It also provides for customary indemnification by each of the Company and the underwriters against certain liabilities and customary contribution provisions in respect of those liabilities.

The New Notes were issued as additional notes under the Base Indenture, dated as of May 10, 2013 (the “Base Indenture”), by and between the Company and U.S.

Prompts

Saratoga Investment Corp New (ticker SAR), listed in United States.

Company History

Date Change Detail
Aug 3, 2010 Renamed GSC INVESTMENT CORP. → SARATOGA INVESTMENT CORP.
— Former tickers SAT

ETFs Holding Saratoga Investment Corp New

ETF Weight in ETF Shares Market value As of
LBO 0.06% 346 $ 0.00 Nov 18, 2026
PFRL 0.05% 2,975 $ 72.382K Nov 18, 2026
JSTC 0.00% 6,625.94 $ 1,765.83 Nov 17, 2026

Securities

Ticker Type Class Market Exchange Last price Price date
SAR canonical Common share — US nyse 14.83 USD 2026-10-09
SAJ Bond — US nyse — —
SAT Bond — US nyse — —
SAY Bond — US nyse — —
SAZ Bond — US nyse — —
SAV Bond — US nyse — —
SAX Bond — US nyse — —